Table 1.
Demographics, Clinical Characteristics and Pathologic Features of Patients who Underwent Thyroid Lobectomy
| Lobectomy n=32,119 |
|
|---|---|
| Median Age, years (IQR) | 48 (38–59) |
| Female | 25,438 (79) |
| Race | |
| White | 23,620 (74) |
| White Hispanic | 3,578 (11) |
| Black | 2,646 (8) |
| Other | 2,275 (7) |
| Urban/Rural | |
| Metro | 25,336 (84) |
| Urban | 4,213 (14) |
| Rural | 510 (2) |
| Facility Type | |
| Community | 20,495 (66) |
| Academic | 10,639 (34) |
| Region | |
| East | 9,045 (28) |
| South | 10,811 (34) |
| Mid-West | 7,536 (23) |
| Mountain/Pacific | 4,727 (15) |
| Insurance status | |
| Private | 23,054 (73) |
| Uninsured | 840 (3) |
| Medicaid | 1,629 (5) |
| Medicare | 5,546 (18) |
| Military | 297 (1) |
| Charlson-Deyo Comorbidity Score | |
| 0 | 17,735 (86) |
| 1 | 2,440 (12) |
| 2 | 486 (2) |
| Histology | |
| Papillary Carcinoma | 26,759 (83) |
| Follicular Carcinoma | 3,550 (11) |
| Hürthle Cell Carcinoma | 1,810 (6) |
| Stage | |
| I | 18,087 (78) |
| II | 3,297 (14) |
| III | 1,575 (7) |
| IV | 328 (1) |
| Median Tumor Size, cm (IQR) | 1 (0.4–2.5) |
| Extrathyroidal Extension | |
| No | 20,584 (96) |
| Yes | 927 (4) |
| Lymph Node Status | |
| Not examined | 23,699 (75) |
| No | 6,628 (21) |
| Yes | 1,123 (4) |
| Distant Metastases | |
| No | 18,019 (99.6) |
| Yes | 74 (0.41) |
| Radioiodine Utilization | |
| No | 23,815 (76) |
| Yes | 7,585 (24) |
Values are presented as n (%) or median with interquartile range (IQR) as indicated